Erratum to: Osteoporos Int
DOI: 10.1007/s00198-015-3386-5
Dear Editor,
In response to the communication from Drs. Bolland, Avenell, Grey, and Reid [1], we offer the following additional data and analyses. We apologize for several errors in Table 1 of the original publication [2]; the updated table is reproduced here (Table 1). We also offer the following method clarifications:
If studies reported multiple results, we used the data from participants who completed the studies (ie, per-protocol analysis).
Porthouse et al. stated: “In our unadjusted analysis we present the incidence of fracture by equally or unequally allocated groups as in any meta-analysis these need to be entered as two separate studies.” Therefore we treated these data as two studies since there was no overlapping in study participants among groups.
RRs were calculated using the original numbers of events and non-events in each group.
Table 1.
Study | Status | Subgroup | Vitamin D (IU/day) | Calcium (mg/day) | Number of total fracture events/total | Number of hip fracture events/total | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Reported RR/HR (95 % CI) | Calculated RR (95 % CI) | Treatment | Control | Reported RR/HR (95 % CI) | Calculated RR (95 % CI) | Treatment | Control | |||||
Chapuy et al, 1992 [3] | Institutionalized | 800 | 1200 | ND |
0.69 (0.51, 0.93) |
66/877 | 97/888 | ND |
0.57 (0.34, 0.97) |
21/877 | 37/888 | |
Chapuy et al, 2002 [4] | Institutionalized | 800 | 1200 | ND | ND | ND | ND |
Placebo vs. treatment 1.69 (0.96–3) |
0.62 (0.36, 1.07) |
27/393 | 21/190 | |
Dawson-Hughes et al, 1997 [5] | Community-dwelling | 700 | 500 |
0.4 (0.2, 1.0) |
0.37 (0.19, 0.72) |
11/170 | 26/148 | ND |
0.29 (0.01, 7.08) |
0/170 | 1/148 | |
Porthouse et al, 2005 [6] | Community-dwelling | Unequally allocated group | 800 | 1000 | ND |
0.96 (0.64, 1.43) |
34/714 | 69/1391 | ND |
0.39 (0.11, 1.34) |
3/714 | 15/1391 |
Porthouse et al, 2005 [6] | Community-dwelling | Equally allocated group | 800 | 1000 | ND |
1.08 (0.61, 1.91) |
24/607 | 22/602 | ND |
2.48 (0.48, 12.78) |
5/607 | 2/602 |
Prentice et al, 2013 [7]a | Community-dwelling | 400 | 1000 | ND |
0.92 (0.80, 1.04) |
405/7530b | 458/7801b | ND |
0.53 (0.31, 0.93) |
19/7530b | 35/7406b | |
Salovaara et al, 2010 [8] | Community-dwelling | 800 | 1000 |
Adjusted HR 0.83 (0.61, 1.12) |
0.84 (0.63, 1.13) |
78/1586 | 94/1609 |
Adjusted HR 2.23 (0.41–12.29) |
2.03 (0.37, 11.06) |
4/1586 | 2/1609 | |
Grant et al, 2015 [9]c | Community-dwelling with history of fracture | 800 | 1000 | ND |
0.95 (0.79, 1.15) |
179/1306 | 192/1332 | ND | ND | ND | ND | |
Harwood et al, 2004 [10] | Community-dwelling with history of fracture | 800 | 1000 | ND |
0.72 (0.19, 2.78) |
3/29 | 5/35 | ND | ND | ND | ND | |
Total (random model) |
0.86 (0.75, 0.98) |
800/12819 | 963/13806 |
0.61 (0.46, 0.82) |
79/11877 | 113/12234 |
CI confidence interval, ND no data, RR relative risk, HR hazard ratio, WHI Women’s Health Initiative
aData analyzing the WHI for adherence to assigned pills and no personal use of supplements from Table 6 in Prentice et al. [7]
bData provided from WHI investigators
cThe results from data of fracture confirmed by radiography
After incorporating the above suggestions from Bolland et al., the overall RR (95 % CI) for total fractures changed from 0.85 (0.73–0.98) to 0.86 (0.75–0.98) (Fig. 1), and the overall RR (95 % CI) for hip fractures changed from 0.70 (0.56–0.87) to 0.61 (0.46–0.82) (Fig. 2). These alterations do not affect the original publication’s conclusions. These data could further suggest that calcium with vitamin D supplementation may have a greater impact on preventing hip fractures than originally described.
We also apologize for a typographical error in the original text [2]. The dataset contains 192 hip fractures, as listed in the original publication’s table (not 195). Since the number of 192 hip fractures were used in the data analysis, this error did not affect the outcome of the study.
Acknowledgments
The authors would like to thank Dr. Mei Chung and Zhuxuan Fu for their help in running the additional meta-analyses provided here.
Funding
Funding sources for the original analyses (DOI: 10.1007/s00198-015-3386-5) were declared in the publication. The authors have not received additional funding or compensation for the new work reported here.
Compliance with ethical standards
Conflicts of interest
The authors declared all conflicts of interest in the original publication (DOI: 10.1007/s00198-015-3386-5).
Footnotes
The online version of the original article can be found at 10.1007/s00198-015-3386-5.
Contributor Information
C. M. Weaver, Email: weavercm@purdue.edu
B. Dawson-Hughes, Email: bess.dawson-hughes@tufts.edu
J. M. Lappe, Email: joanlappe@creighton.edu
T. C. Wallace, Phone: 270.839.1776, FAX: 703.414.3742, Email: taylor.wallace@me.com
References
- 1.Bolland MJ, Avenell A, Grey A, Reid IR. Errors in NOF meta-analyses of calcium and vitamin D supplements. Osteoporos Int. 2016 doi: 10.1007/s00198-015-3466-6. [DOI] [PubMed] [Google Scholar]
- 2.Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, Liu S, Looker AC, Wallace TC, Wang DD. Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27:367–376. doi: 10.1007/s00198-015-3386-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327:1637–1642. doi: 10.1056/NEJM199212033272305. [DOI] [PubMed] [Google Scholar]
- 4.Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, Garnero P, Meunier PJ. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int. 2002;13:257–264. doi: 10.1007/s001980200023. [DOI] [PubMed] [Google Scholar]
- 5.Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium with combined vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670–676. doi: 10.1056/NEJM199709043371003. [DOI] [PubMed] [Google Scholar]
- 6.Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville J, Francis R, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ. Randomised controlled trial of calcium supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005;330:1003. doi: 10.1136/bmj.330.7498.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, LeBlanc ES, Cauley JA, Rossouw JE. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int. 2013;24:567–580. doi: 10.1007/s00198-012-2224-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Salovaara K, Tuppurainen M, Kärkkäinen M, Rikkonen T, Sandini L, Sirola J, Honkanen R, Alhava E, Kröger H. Effect of vitamin D(3) and calcium on risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial – the OSTPRE-FPS. J Bone Miner Res. 2010;25:1487–1495. doi: 10.1002/jbmr.48. [DOI] [PubMed] [Google Scholar]
- 9.Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA, RECORD Trial Group Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or Vitamin D, RECORD): a randomised placebo controlled trial. Lancet. 2005;365:1621–1628. doi: 10.1016/S0140-6736(05)63013-9. [DOI] [PubMed] [Google Scholar]
- 10.Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ, Nottingham Neck of Femur (NONOF) Study A randomised, controlled comparison of different calcium with combined vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Aging. 2004;33:45–51. doi: 10.1093/ageing/afh002. [DOI] [PubMed] [Google Scholar]